At the moment, there are no entries available for display

" The year 2024/25 marked the strategic evolution of Nawaloka Hospitals Colombo PLC, steered by the foundation of resilience of the past few years to embrace innovation, clinical excellence and patient care. "
Chairman’s Message
The year 2024/25 marked the strategic evolution of Nawaloka Hospitals Colombo PLC, where the resilience of recent years was transformed into renewed momentum for growth. Our core focus on patient wellbeing, technology adaptation, process improvements, and ethical stewardship shaped our progress and illustrated our undisputed leadership in the private healthcare sector in Sri Lanka. In this backdrop, I am pleased to present the financial and non-financial performance of Nawaloka Hospitals Colombo PLC for the financial year 2024/25.
In spite of industry-wide cost pressure, Nawaloka recorded a revenue of Rs. 11,013 Mn., indicating a 6% year-on-year growth. Meanwhile, our net profit after tax reached Rs. 56 Mn., representing a year-on-year growth of 119%. Medical tourism and increased patient volumes supported this turnaround, reflecting the strength of our strategy. Following the close of the financial year, the Group concluded a landmark debt settlement with Hatton National Bank PLC. This achievement has fortified our financial foundation, strengthened our financial stewardship, and enhanced our ability to channel resources into future growth. The successful resolution of this facility with HNB stands as a clear endorsement of the trust and confidence placed in Nawaloka Hospitals, and provides us with a stronger platform to pursue our long-term strategic ambitions while consistently delivering sustainable value to our stakeholders.
Furthermore, the share price of Nawaloka Hospitals, which stood at Rs. 3.90 as of 31 March 2024, has since appreciated to Rs. 8.00. This outstanding performance has elevated our market capitalisation from approximately Rs. 5.5 Bn. to Rs. 11.3 Bn., reflecting growth of more than 105%. When compared with our Group net assets of Rs. 4.9 Bn., this valuation at over 2.3 times book value is a clear testament to investor confidence and the substantial wealth created for our shareholders. This achievement was made possible by the collective and unwavering commitment of our staff, whose dedication continues to drive our success.
At Nawaloka, we remain a step ahead, ensuring our patients experience tomorrow’s healthcare today. This forward-looking approach earned us recognition as the Leading Hospital in AI & Innovation – Asia Pacific 2025 at the Global Health Asia Pacific Summit in Bangkok, and honored for excellence in the Healthcare Sector at the National Business Excellence Awards.
Stewardship
Our governance culture, shaped by the “Do No Harm” approach, anchors our integrity. Ethical stewardship guides us in clinical, financial, and social spheres, ensuring patient safety, fairness, and accountability. Oversight of ESG initiatives, data protection, and clinical integrity is embedded in our governance framework, with the Board ensuring alignment to national and international standards.
Future Outlook
With a stable foundation, Nawaloka Hospitals Colombo PLC is well-positioned to meet evolving healthcare needs through technology, infrastructure, knowledge, and partnerships, while remaining dedicated to creating sustainable value for all stakeholders.
I extend my heartfelt gratitude to the Board of Directors for their guidance, to our consultants for their expertise, to our employees for their loyalty and professionalism, to our investors and partners for their confidence, and, most importantly, to our patients for entrusting us with their care.

Dr Jayantha Dharmadasa
Chairman/Chief Executive Officer
04 September 2025